Greenwich LifeSciences, Inc. (GLSI) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 284.37M |
| Enterprise Value | 291.11M |
| P/E Ratio | -15.13 |
| PEG Ratio | 0.7 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 65.64 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -15.54 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.07 |
| Return On Equity | -8.14 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1,779 |
| EBITDA | -19.36M |
| Net Income | -19.36M |
| Diluted EPS | -1.43 |
| Total Cash | 10.51M |
| Total Cash/Share | 0.72 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.01 |
| Book Value Per Share | 0.36 |
| 52-Week Change | 171.12 |
| 52-Week High | 34.1 |
| 52-Week Low | 7.78 |
| Moving Average 50 Days | 24.82 |
| Moving Average 200 Days | 19.21 |
| Average Volume | 136,611 |
| Shares Outstanding | 14.68M |
| % Held by Institutions | 12.56 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |